Fenozolone
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (RS)-2-ethylamino-5-phenyl-1,3-oxazol-4-one | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Oral |
| Identifiers | |
| CAS number | 15302-16-6  |
| ATC code | N06BA08 |
| PubChem | CID 71682 |
| ChemSpider | 64736 |
| UNII | 1NZI4LMU6G |
| KEGG | D07344 |
| Chemical data | |
| Formula | C11H12N2O2 |
| Mol. mass | 204.225 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
Fenozolone (Ordinator) was developed by Laboratoires Dausse in the 1960s[1] and is a psychoactive drug and stimulant related to pemoline and 4-methylaminorex which acts as a norepinephrine-dopamine releasing agent (NDRA).[2]
[edit] See also
[edit] References
- ^ DE Patent 129710 - 5-phenyl-2-ethylamino-4-oxazolinone and its preparation
- ^ Gielsdorf W (February 1982). "Determination of the psychostimulants pemoline, fenozolone and thozalinone in human urine by gas chromatography/mass spectrometry and thin layer chromatography". Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie 20 (2): 65–8. PMID 6121837.
|
|
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
